Preface on Lung Cancer Immunotherapy1
Immunotherapy for lung cancer
Translational Lung Cancer Research
2015;
4
(6)
:675-677
.
(28 December 2015)
Review Article on Lung Cancer Immunotherapy2
Lung cancer in HIV-infected patients in the combination antiretroviral treatment era
Translational Lung Cancer Research
2015;
4
(6)
:678-688
.
(28 December 2015)
Cancer stem cells and immunoresistance: clinical implications and solutions
Translational Lung Cancer Research
2015;
4
(6)
:689-703
.
(28 December 2015)
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer
Translational Lung Cancer Research
2015;
4
(6)
:704-712
.
(28 December 2015)
Platelets and their role in cancer evolution and immune system
Translational Lung Cancer Research
2015;
4
(6)
:713-720
.
(28 December 2015)
Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity
Translational Lung Cancer Research
2015;
4
(6)
:721-727
.
(28 December 2015)
Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role
Translational Lung Cancer Research
2015;
4
(6)
:728-742
.
(28 December 2015)
Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis
Translational Lung Cancer Research
2015;
4
(6)
:743-751
.
(28 December 2015)
Immunotherapy meets targeted therapy: will this team end the war against cancer?
Translational Lung Cancer Research
2015;
4
(6)
:752-755
.
(28 December 2015)
Results of clinical trials with anti-programmed death 1/programmed death ligand 1 inhibitors in lung cancer
Translational Lung Cancer Research
2015;
4
(6)
:756-762
.
(28 December 2015)
Original Article
The incidence and mortality of lung cancer and their relationship to development in Asia
Translational Lung Cancer Research
2015;
4
(6)
:763-774
.
(28 December 2015)
Crocin inhibits cell proliferation and enhances cisplatin and pemetrexed chemosensitivity in lung cancer cells
Translational Lung Cancer Research
2015;
4
(6)
:775-783
.
(28 December 2015)
Lung cancer treatment outcomes in recipients of lung transplant
Translational Lung Cancer Research
2015;
4
(6)
:784-791
.
(28 December 2015)
Evidence-Based Medicine2
The relationship between BIM deletion polymorphism and clinical significance of epidermal growth factor receptor-mutated nonsmall cell lung cancer patients with epidermal growth factor receptor-tyrosine kinase inhibitor therapy: a meta-analysis
Translational Lung Cancer Research
2015;
4
(6)
:792-796
.
(28 December 2015)
Editorial
Alectinib in RET-rearranged non-small cell lung cancer—Another progress in precision medicine?
Translational Lung Cancer Research
2015;
4
(6)
:797-800
.
(28 December 2015)
Nivolumab for refractory metastatic squamous non-small-cell lung cancer: fulfilling an unmet need
Translational Lung Cancer Research
2015;
4
(6)
:801-803
.
(28 December 2015)
Surrogate clinical endpoints to predict overall survival in non-small cell lung cancer trials—are we in a new era?
Translational Lung Cancer Research
2015;
4
(6)
:804-808
.
(28 December 2015)
Whacking a mole-cule: clinical activity and mechanisms of resistance to third generation EGFR inhibitors in EGFR mutated lung cancers with EGFR-T790M
Translational Lung Cancer Research
2015;
4
(6)
:809-815
.
(28 December 2015)
Shedding light on the molecular determinants of response to anti-PD-1 therapy
Translational Lung Cancer Research
2015;
4
(6)
:816-819
.
(28 December 2015)
Commentary
MET exon 14 deletion (METex14): finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of “40 years of wilderness” and into a clear path of regulatory approval
Translational Lung Cancer Research
2015;
4
(6)
:820-824
.
(28 December 2015)
Meet the Professor3
Professor Eric Lim: blood-based genetic test, a brave try to detect non-smoking lung cancer
Translational Lung Cancer Research
2015;
4
(6)
:825-827
.
(28 December 2015)
News
Translational Lung Cancer Research is newly included by Scopus
Translational Lung Cancer Research
2015;
4
(6)
:828-835
.
(28 December 2015)
Disclosure:
1. The series “Lung Cancer Immunotherapy” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. María González-Cao served as the unpaid Guest Editor for the series.
2. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
3. The series “Meet the Professor” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
